Search results
- (-) Remove Pipeline filter Pipeline
AXO–LENTI–PD (Sio Gene Therapies)
AXO–LENTI–PD (Sio Gene Therapies)
Gene-based treatment for Parkinson's disease
Status: Phase II
SAR 422459 (Sanofi)
SAR422459
Gene therapy for Stargardt disease
Licensed to Sanofi: Phase II ongoing
OXB–302*
OXB–302*
Gene-based immunotherapy targeting blood cancer
Status: Pre–Clinical complete
SAR 421869 (Sanofi)
SAR 421869
Gene therapy for Usher syndrome type 1B
Licensed to Sanofi: Phase I/IIa trial ongoing
Kymriah®* (Novartis)
Kymriah®* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
3rd CAR–T* (Novartis)
3rd CAR–T* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
4th CAR-T* (Novartis)
4th CAR-T* (Novartis)
This is a partner product. Visit the relevant partner website for further information.
OTL–201* (Orchard Therapeutics)
OTL–201* (Orchard Therapeutics)
This is a partner product. Visit the relevant partner website for further information.
Other* (Orchard Therapeutics)
Other* (Orchard Therapeutics)
This is a partner product. Visit the relevant partner website for further information.
2nd CAR-T* (Novartis)
2nd CAR-T* (Novartis)
This is a partner product. Visit the relevant partner website for further information.